Results 21 to 30 of about 264,729 (304)

Ten-year retrospect of the investigation of proximal limbs metastasis in cancer: a multi-center study on survival outcome, limb function status and surgical procedures analysis

open access: yesBMC Cancer, 2023
Background The aim of study was to evaluate survival outcome and limb function in cancer patients with proximal limbs metastasis. Associated factors on survival outcome and limb function were identified.
Chao Zhang   +9 more
doaj   +1 more source

Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis [PDF]

open access: yes, 2022
Breast cancer bone metastasis is currently incurable. Evidence suggests that inhibiting IL-1 signalling with the IL1R antagonist, Anakinra, or the IL1β antibody, Canakinumab, prevents metastasis and almost eliminates breast cancer growth in the bone.
Marwa A. Alsharif   +22 more
core   +1 more source

Investigating the contribution of the unfolded protein response to prostate cancer bone metastasis

open access: yes, 2022
The majority of deaths from prostate cancer (PCa) arise following metastasis, particularly to the skeleton. ER stress and the unfolded protein response (UPR) promote primary PCa, however, the contribution of the UPR to PCa bone metastasis remains unknown.
Kaya, Zeynep
core   +1 more source

Basement membrane-rich Organoids with functional human blood vessels are permissive niches for human breast cancer metastasis [PDF]

open access: yes, 2013
Metastasic breast cancer is the leading cause of death by malignancy in women worldwide. Tumor metastasis is a multistep process encompassing local invasion of cancer cells at primary tumor site, intravasation into the blood vessel, survival in systemic ...
David Sánchez-Martín (264504)   +39 more
core   +1 more source

Immune microenvironment in breast cancer bone metastasis

open access: yes, 2021
Bone metastasis is the major cause of death in breast cancer. However, the underlying mechanisms of bone metastasis progression are still largely unknown.
Ma, Ruoyu
core   +1 more source

Treatment of Bone Metastasis

open access: yesCurrent Oncology, 2022
The incidence of metastatic bone disease is increasing, as patients with cancer are living longer [...]
openaire   +3 more sources

Correlation of Systemic Immune Inflammatory Index and Tumor Markers with Bone Metastasis of Lung Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To evaluate the value of the systemic immune-inflammatory index (SII), CEA, Cyfra21-1, and NSE in predicting and diagnosing bone metastasis of lung cancer. Methods The clinical data of 618 patients with lung cancer were retrospectively analyzed.
TANG Min, LI Guixiang
doaj   +1 more source

Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis [PDF]

open access: yesEndocrinology and Metabolism, 2016
Bone metastasis is a frequent occurrence in breast cancer, affecting more than 70% of late stage cancer patients with severe complications such as fracture, bone pain, and hypercalcemia.
Yibin Kang
doaj   +1 more source

Models of Bone Metastasis

open access: yesJournal of Visualized Experiments, 2012
Bone metastases are a common occurrence in several malignancies, including breast, prostate, and lung. Once established in bone, tumors are responsible for significant morbidity and mortality. Thus, there is a significant need to understand the molecular mechanisms controlling the establishment, growth and activity of tumors in bone.
J Preston, Campbell   +4 more
openaire   +3 more sources

Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

open access: yesBMC Cancer, 2021
Background Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in HCC bone metastasis.
Li Zhang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy